EC: 1.14.13.32
albendazole monooxygenase (albendazole,NADPH:oxygen oxidoreductase (sulfoxide-forming))
Pathways
| pathway id | name |
|---|---|
| BioCyc:META_PWY66-201 | nicotine degradation IV |
| BioCyc:MOUSE_PWY66-201 | nicotine degradation II |
| Reactome:R-BTA-1430728 | Metabolism |
| Reactome:R-BTA-211945 | Phase I - Functionalization of compounds |
| Reactome:R-CFA-1430728 | Metabolism |
| Reactome:R-HSA-211859 | Biological oxidations |
| Reactome:R-HSA-217271 | FMO oxidises nucleophiles |
| Reactome:R-MMU-1430728 | Metabolism |
| Reactome:R-MMU-211859 | Biological oxidations |
| Reactome:R-MMU-217271 | FMO oxidises nucleophiles |
| Reactome:R-RNO-211945 | Phase I - Functionalization of compounds |
| Reactome:R-BTA-211859 | Biological oxidations |
| Reactome:R-BTA-217271 | FMO oxidises nucleophiles |
| Reactome:R-RNO-211859 | Biological oxidations |
| Reactome:R-RNO-217271 | FMO oxidises nucleophiles |
| Reactome:R-CFA-211859 | Biological oxidations |
| Reactome:R-CFA-217271 | FMO oxidises nucleophiles |
| Reactome:R-HSA-211945 | Phase I - Functionalization of compounds |
| Reactome:R-MMU-211945 | Phase I - Functionalization of compounds |
| Reactome:R-RNO-1430728 | Metabolism |
| Reactome:R-CFA-211945 | Phase I - Functionalization of compounds |
| Reactome:R-HSA-1430728 | Metabolism |
| PathBank:SMP0000628 | Nicotine Metabolism Pathway |
| PathBank:SMP0000606 | Tamoxifen Metabolism Pathway |
| PathBank:SMP0000471 | Tamoxifen Action Pathway |
| PathBank:SMP0000431 | Nicotine Action Pathway |